Melodi Matrix™ in Breast Reconstruction

Description

Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage prepectoral alloplastic breast reconstruction.

Conditions

Breast Reconstruction

Study Overview

Study Details

Study overview

Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage prepectoral alloplastic breast reconstruction.

Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction With Infection Outcomes Assessment (ARIA)

Melodi Matrix™ in Breast Reconstruction

Condition
Breast Reconstruction
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Salt Lake City

University of Utah, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Female.
  • * Age 22 or older at the time of enrollment.
  • * Is scheduled to undergo unilateral or bilateral mastectomy (including prophylactic) with immediate two-stage post-mastectomy alloplastic prepectoral breast reconstruction.
  • * Is able to and willing to comply with the study requirements and providing informed consent.
  • * Has prior history of neoadjuvant radiotherapy.
  • * Has had prior history of failed tissue expansion or breast implantation at the intended reconstruction site.
  • * Has an active abscess or infection requiring antibiotics anywhere in their body within 30 days.
  • * Has a Body Mass Index (BMI) \< 14 or \> 40.
  • * Is pregnant or is nursing; or plans to become pregnant during the course of the study.
  • * Has any connective tissue/autoimmune disorder or rheumatoid disease.
  • * Has known allergies to study device materials.
  • * Is participating in another interventional research study that may interfere with study endpoints.
  • * Has limited life expectancy or co-morbid conditions, social/psychological problems, or cognitive impairments that precludes participation.
  • * Has a medical condition or is taking medications that would result in elevated risk and/or affect the validity of the study.
  • * Intraoperative assessment demonstrates unfavorable conditions (i.e., poor mastectomy skin flap thickness or viability) for immediate, two-stage post-mastectomy alloplastic prepectoral reconstruction in any breast.

Ages Eligible for Study

22 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Melodi Health, Inc.,

Study Record Dates

2028-06